Address

Telegraph Hill Partners
360 Post Street
Suite 601
San Francisco, CA 94018
United States

Open map


Recent investment activity

KANDO id: 27678

Corporate information

Registration country

Funds managed

Fund Type Vintage Currency Committed capital
Telegraph Hill Partners III LP Venture 2013 USD 310,000,000
Telegraph Hill Partners II Venture 2005 USD 150,000,000
Telegraph Hill Partners [I] Venture 2001

Funding rounds

Investment preferences

Investment criteria
Telegraph Hill Partners believes that sometimes the most attractive investments are in businesses that are behind the scenes but create the foundation for the entire industry. We seek to partner with these companies by providing capital and strategic guidance to innovate and expand. We work with commercial companies in growth areas within the healthcare sector, including life science technologies, medical devices, chemistry and reagent suppliers, and healthcare services.
Top investment portfolio themes


Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 27
Profile Country Date Funding
AcroMetrix Corp N/A
Althea Technologies Inc N/A
Ambion Inc N/A
Applied Precision Inc N/A
Asuragen Inc Fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with emphasis on microRNA. N/A
Aurora Discovery N/A
Dharmacon Inc N/A
Estech N/A
Freedom Innovations LLC N/A
Interface Catheter solutions N/A
Kinetikos Medical Inc N/A
LDR Holding Corp N/A
LDR Holding Corp N/A
LDR Spine USA Inc Orthopedic spine company with a full line of spinal implant devices. N/A
MedPricer.com Inc N/A
NEXUS Biosystems Inc N/A
PneumRx Inc Developer of minimally invasive treatments for emphysema patients. N/A
RareCyte Inc N/A
SwitchGear Genomics Inc N/A
VidaCare Corp N/A
Accumetrics Inc Innovative developer and manufacturer of diagnostic instrumentation and test kits. Series B
AltheaDx Inc N/A
AngioScore Inc Developer, maker, and seller of leading edge tools for endovascular therapy. Series E
AngioScore Inc Developer, maker, and seller of leading edge tools for endovascular therapy. Series D
Aquaro Histology Inc Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory. Series A led the round

Former team members

Employee Company Position Email
Jeffrey Calhoun Tailwind Capital Partners LLC [email protected]

Selected Products / Customers

Financials